Melatonin inhibits visfatin-induced inducible nitric oxide synthase expression and nitric oxide production in macrophages

Journal of Pineal Research

Volumn 55, Issue 3, 2013, Pages 294-303

  Kang, Young Soon ^a   Kang, Yong Gyu ^a   Park, Hyun Joo ^a   Wee, Hee Jun ^b   Jang, Hye Ock ^a   Bae, Moon Kyoung ^a   Bae, Soo Kyung ^a  

^a Pusan National University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

inducible nitric oxide synthase; macrophages; melatonin; NF B; STAT3; visfatin

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE 2; LIPOPOLYSACCHARIDE; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; WESTERN BLOTTING;

INDUCIBLE NITRIC OXIDE SYNTHASE; MACROPHAGES; MELATONIN; NF-ΚB; STAT3; VISFATIN;

ANIMALS; ANTIOXIDANTS; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; JANUS KINASE 2; JANUS KINASE 3; MACROPHAGES, PERITONEAL; MELATONIN; MICE; MICE, MUTANT STRAINS; MITOGEN-ACTIVATED PROTEIN KINASE 8; MITOGEN-ACTIVATED PROTEIN KINASE 9; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELA; UP-REGULATION;

EID: 84883743553     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12072     Document Type: Article

References (53)

1. Bogdan C,. Nitric oxide and the immune response. Nat Immunol 2001; 2: 907-916.
2. Moncada S, Palmer R, Higgs E,. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
3. Palmer R, Ferrige A, Moncada S,. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-526.
4. Macmicking J, Xie Q, Nathan C,. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-350.
5. Hibbs JB, Taintor RR, Vavrin Z,. Macrophage cytotoxicity: role for l -arginine deiminase and imino nitrogen oxidation to nitrite. Science 1987; 235: 473-476.
6. Grisham MB, Jourd'Heuil D, Wink DA,. Nitric oxid. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol 1999; 276: G315-G321.
7. Szabo C,. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz 1995; 3: 2.
8. Nathan C,. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
9. Nathan C, Xie QW,. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78: 915-918.
10. Dawn B, Xuan Y, Guo Y, et al. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 2004; 64: 61-71.
11. Kitade H, Sakitani K, Inoue K, et al. Interleukin 1 β markedly stimulates nitric oxide formation in the absence of other cytokines or lipopolysaccharide in primary cultured rat hepatocytes but not in Kupffer cells. Hepatology 1996; 23: 797-802.
12. Sonoli S, Shivprasad S, Prasad C, et al. Visfatin-a review. Eur Rev Med Pharmacol Sci 2011; 15: 9-14.
13. Kim S, Bae S, Choi K, et al. Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochem Biophys Res Commun 2007; 357: 150-156.
14. Kang Y, Bae M, Kim J, et al. Visfatin induces neurite outgrowth in PC12 cells via ERK1/2 signaling pathway. Neurosci Lett 2011; 504: 121-126.
15. Li Y, Zhang Y, Dorweiler B, et al. Extracellular Nampt promotes macrophage survival via a nonenzymatic interleukin-6/STAT3 signaling mechanism. J Biol Chem 2008; 283: 34833-34843.
16. Zhang W, Xie Y, Wang T, et al. Neuronal protective role of PBEF in a mouse model of cerebral ischemia. J Cereb Blood Flow Metab 2010; 30: 1962-1971.
17. Borradaile NM, Pickering JG,. Nicotinamide phosphoribosyltransferase imparts human endothelial cells with extended replicative lifespan and enhanced angiogenic capacity in a high glucose environment. Aging Cell 2009; 8: 100-112.
18. Bi T, Che X,. Nampt/PBEF/visfatin and cancer. Cancer Biol Ther 2010; 10: 119-125.
19. Kim S, Park H, Bae Y, et al. Curcumin down-regulates visfatin expression and inhibits breast cancer cell invasion. Endocrinology 2012; 153: 554-563.
20. Luk T, Malam Z, Marshall JC,. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008; 83: 804-816.
21. Moschen AR, Gerner RR, Tilg H,. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders. Curr Pharm Des 2010; 16: 1913-1920.
22. Meier FM, Frommer KW, Peters MA, et al. Visfatin/pre-B-cell colony-enhancing factor (PBEF), a proinflammatory and cell motility-changing factor in rheumatoid arthritis. J Biol Chem 2012; 287: 28378-28385.
23. Kim S, Bae Y, Bae S, et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells. Biochim Biophys Acta 2008; 1783: 886-895.
24. Liu S, Qiao S, Yuan J, et al. Visfatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells. Horm Metab Res 2008; 41: 281-286.
25. Romacho T, Azcutia V, Vazquez-Bella M, et al. Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity. Diabetologia 2009; 52: 2455-2463.
26. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153.
27. Stehle JH, Saade A, Rawashdeh O, et al. A survey of molecular details in the human pineal gland in the light of phylogeny, structure, function and chronobiological diseases. J Pineal Res 2011; 51: 17-43.
28. Reiter RJ,. The pineal and its hormones in the control of reproduction in mammals. Endocr Rev 1980; 1: 109-131.
29. Poeggeler B, Reiter RJ, Tan DX, et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168.
30. Hardeland R, Tan D, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
31. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
32. Mauriz JL, Collado PS, Veneroso C, et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
33. Reiter RJ, Tan DX, Manchester LC, et al. Medical implications of melatonin: receptor-mediated and receptor-independent actions. Adv Med Sci 2007; 52: 11-28.
34. Carrillo-Vico A, Lardone PJ, Naji L, et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005; 39: 400-408.
35. Pozo D, Reiter RJ, Calvo JR, et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65: 430-442.
36. Gilad E, Wong HR, Zingarelli B, et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFκB activation. FASEB J 1998; 12: 685-693.
37. Tamura EK, Cecon E, Monteiro AWA, et al. Melatonin inhibits LPS-induced NO production in rat endothelial cells. J Pineal Res 2009; 46: 268-274.
38. Mohan N, Sadeghi K, Reiter RJ, et al. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kB. Biochem Mol Biol Int 1995; 37: 1063-1070.
39. Chuang JI, Mohan N, Meltz ML, et al. Effect of melatonin on NF-kappa-B DNA-binding activity in the rat spleen. Cell Biol Int 1996; 20: 687-692.
40. Revollo JR, Körner A, Mills KF, et al. Nampt/PBEF/visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme. Cell Metab 2007; 6: 363-375.
41. Rossol M, Heine H, Meusch U, et al. LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol 2011; 31: 379.
42. Rodríguez A, Fortuño A, Gõmez-Ambrosi J, et al. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism. Endocrinology 2007; 148: 324-331.
43. Raso GM, Pacilio M, Esposito E, et al. Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1. Br J Pharmacol 2002; 137: 799-804.
44. Cai XJ, Chen L, Feng M, et al. Adiponectin inhibits lipopolysaccharide- induced adventitial fibroblast migration and transition to myofibroblasts via AdipoR1-AMPK-iNOS pathway. Mol Endocrinol 2010; 24: 218-228.
45. Ouchi N, Kihara S, Funahashi T, et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14: 561-566.
46. Wellen KE, Hotamisligil GS,. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-1788.
47. Duan W, Yang Y, Yi W, et al. New role of JAK2/STAT3 signaling in endothelial cell oxidative stress injury and protective effect of melatonin. PLoS ONE 2013; 8: e57941.
48. Zhang S, Li W, Gao Q, et al. Effect of melatonin on the generation of nitric oxide in murine macrophages. Eur J Pharmacol 2004; 501: 25-30.
49. Qin W, Lu W, Li H, et al. Melatonin inhibits IL1beta-induced MMP9 expression and activity in human umbilical vein endothelial cells by suppressing NF-kappaB activation. J Endocrinol 2012; 214: 145-153.
50. Wang P, Vanhoutte PM, Miao C,. Visfatin and cardio-cerebro-vascular disease. J Cardiovasc Pharmacol 2012; 59: 1-9.
51. Zhang LQ, Heruth DP, Ye SQ,. Nicotinamide phosphoribosyltransferase in human diseases. J Bioanal Biomed 2011; 3: 13-25.
52. Bian K, Ghassemi F, Sotolongo A, et al. NOS-2 signaling and cancer therapy. IUBMB Life 2012; 64: 676-683.
53. Gallí M, van Gool F, Rongvaux A, et al. The nicotinamide phosphoribosyltransferase: a molecular link between metabolism, inflammation, and cancer. Cancer Res 2010; 70: 8-11.